(R,R)-Formoterol-L-(+)-tartrate

(2R,3R)-2,3-Dihydroxybernsteinsäure --N-{2-hydroxy-5-[(1R)-1-hydroxy-2-{[(2R)-1-(4-methoxyphenyl)-2-propanyl]amino}ethyl]phenyl}formamid (1:1)

(2R,3R)-2,3-Dihydroxybutandisäure--N-{2-hydroxy-5-[(1R)-1-hydroxy-2-{[(1R)-2-(4-methoxyphenyl)-1-methylethyl]amino}ethyl]phenyl}formamid(1:1)

(2R,3R)-2,3-Dihydroxysuccinic acid - N-{2-hydroxy-5-[(1R)-1-hydroxy-2-{[(2R)-1-(4-methoxyphenyl)-2-propanyl]amino}ethyl]phenyl}formamide (1:1)

(R,R)-Formoterol-L-(+)-tartrate

200815-49-2

5P8VJ2I235

acide (2R,3R)-2,3-dihydroxybutanedioïque - N-{2-hydroxy-5-[(1R)-1-hydroxy-2-{[(1R)-2-(4-méthoxyphényl)-1-méthyléthyl]amino}éthyl]phényl}formamide (1:1)

Acide (2R,3R)-2,3-dihydroxysuccinique - N-{2-hydroxy-5-[(1R)-1-hydroxy-2-{[(2R)-1-(4-méthoxyphényl)-2-propanyl]amino}éthyl]phényl}formamide (1:1)

Arformoterol (tartrate)

Arformoterol tartrate

Brovana

Butanedioic acid, 2,3-dihydroxy-, (2R,3R)-, compd. with formamide, N-[2-hydroxy-5-[(1R)-1-hydroxy-2-[[(1R)-2-(4-methoxyphenyl)-1-methylethyl]amino]ethyl]phenyl]- (1:1)

Formoterol tartrate

MFCD07785830

N-[2-Hydroxy-5-[(1R)-1-hydroxy-2-[[(1R)-2-(4-methoxyphenyl)-1-methylethyl]amino]ethyl]phenyl]-formamide (2R,3R)-2,3-dihydroxybutanedioate (1:1) (salt)

N-{2-hydroxy-5-[(1R)-1-hydroxy-2-{[(1R)-2-(4-methoxyphenyl)-1-methylethyl]amino}ethyl]phenyl}formamide 2,3-dihydroxybutanedioate (salt)

(2R,3R)-2,3-dihydroxybutanedioic acid; N-{2-hydroxy-5-[(1R)-1-hydroxy-2-{[(2R)-1-(4-methoxyphenyl)propan-2-yl]amino}ethyl]phenyl}formamide

[(2R)-2-(3-formamido-4-hydroxyphenyl)-2-hydroxyethyl]-[(2R)-1-(4-methoxyphenyl)propan-2-yl]azanium;(2R,3R)-2,3,4-trihydroxy-4-oxobutanoate

ArformoterolTartrate

Formamide, N-[2-hydroxy-5-[(1R)-1-hydroxy-2-[[(1R)-2-(4-methoxyphenyl)-1-methylethyl]amino]ethyl]phenyl]-, (2R,3R)-2,3-dihydroxybutanedioate (1:1)

N-[2-hydroxy-5-[(1R)-1-hydroxy-2-[[(1R)-2-(4-methoxyphenyl)-1-methylethyl]amino]ethyl]phenyl]-formamide, (2R,3R)-2,3-dihydroxybutanedioate